These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39304928)

  • 1. STK40 inhibits trophoblast fusion by mediating COP1 ubiquitination to degrade P57
    Li X; Shao LZ; Li ZH; Wang YH; Cai QY; Wang S; Chen H; Sheng J; Luo X; Chen XM; Wang YX; Ding YB; Liu TH
    J Transl Med; 2024 Sep; 22(1):852. PubMed ID: 39304928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p57
    Takahashi K; Yoneyama Y; Koizumi N; Utoguchi N; Kanayama N; Higashi N
    Placenta; 2021 Jan; 104():168-178. PubMed ID: 33360007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate expression of P57kip2 drives trophoblast fusion via cell cycle arrest.
    Song HL; Liu TH; Wang YH; Li FF; Ruan LL; Adu-Gyamfi EA; Hu SC; Chen XM; Ding YB; Fu LJ
    Reproduction; 2021 May; 161(6):633-644. PubMed ID: 33812346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
    Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
    Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiation.
    Kim M; Nakamoto T; Nishimori S; Tanaka K; Chiba T
    EMBO Rep; 2008 Sep; 9(9):878-84. PubMed ID: 18660753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.
    Andresini O; Rossi MN; Matteini F; Petrai S; Santini T; Maione R
    Epigenetics Chromatin; 2019 Jan; 12(1):8. PubMed ID: 30651140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity.
    Zhao R; Yang HY; Shin J; Phan L; Fang L; Che TF; Su CH; Yeung SC; Lee MH
    Cell Cycle; 2013 Mar; 12(6):935-43. PubMed ID: 23421998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
    Hattori N; Davies TC; Anson-Cartwright L; Cross JC
    Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The developmental expression of the CDK inhibitor p57(kip2) (Cdkn1c) in the early mouse placenta.
    Saunders AC; McGonnigal B; Uzun A; Padbury J
    Mol Reprod Dev; 2016 May; 83(5):405-12. PubMed ID: 26988311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
    Tury A; Mairet-Coello G; DiCicco-Bloom E
    Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.
    Chen B; Zhao R; Su CH; Linan M; Tseng C; Phan L; Fang L; Yang HY; Yang H; Wang W; Xu X; Jiang N; Cai S; Jin F; Yeung SC; Lee MH
    Cell Cycle; 2012 Dec; 11(24):4633-41. PubMed ID: 23187808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57
    Qiao E; Chen D; Li Q; Feng W; Yu X; Zhang X; Xia L; Jin J; Yang H
    J Cell Biochem; 2019 Mar; 120(3):3978-3988. PubMed ID: 30378143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts.
    Takahashi K; Kobayashi T; Kanayama N
    Mol Hum Reprod; 2000 Nov; 6(11):1019-25. PubMed ID: 11044465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101.
    Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B
    Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide expression profiling of placentas in the p57Kip2 model of pre-eclampsia.
    Knox KS; Baker JC
    Mol Hum Reprod; 2007 Apr; 13(4):251-63. PubMed ID: 17289831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fbxo22 promotes cervical cancer progression via targeting p57
    Lin M; Zhang J; Bouamar H; Wang Z; Sun LZ; Zhu X
    Cell Death Dis; 2022 Sep; 13(9):805. PubMed ID: 36127346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Beckwith-Wiedemann-Associated
    Stampone E; Bencivenga D; Barone C; Di Finizio M; Della Ragione F; Borriello A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
    Lu Z; Hunter T
    Cell Cycle; 2010 Jun; 9(12):2342-52. PubMed ID: 20519948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
    Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
    Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.